Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
R&D Inquiry Quote
Contact Us Telecon Calls

Apta-Index™: 2F11-14 (ID# 581)

Back to Search Results

2F11-14 (ID# 581)

* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
RNA Ebola virus inhibitory domain (eVP35 IID) (EBOV) (eVP35) Protein 7.1 nM (reported value) 10mM HEPES (pH 7.0), 150mM NaCl, 2mM TCEP (tris(2-carboxyethyl)phosphine), 1mM MgCl2 N/A If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
78 25439.76 g/mole 797500.00 L/(mole·cm) 56.41% 1.25 31.90

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Jennifer M. Binning, Tianjiao Wang, Priya Luthra, Reed S. Shabman, Dominika M. Borek, Gai Liu, Wei Xu, Daisy W. Leung, Christopher F. Basler, and Gaya K. Amarasinghe, “Development of RNA aptamers targeting ebolavirus VP35” Biochemistry 2013, 52, 8406-8419.

Have your aptamer oligo synthesized by one of our AFFILIATES

Community Feedback

Aptagen, LLC | 250 North Main Street | Jacobus, PA 17407

Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
Contact Us Telecon Calls